Margaret Dean, MBA

Margaret Dean, MBA, is Senior Director, Portfolio Oversight, of Fortrea’s Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT). She has 19 years of experience across the product development life cycle from bench research through commercialization, including pharmaceuticals, medical devices and healthcare IT systems. Her therapeutic experience includes acute coronary syndromes in the catheterization lab setting, development of an EMR-based tool for decision support in oncology setting and the delivery of CRO services across multiple rare diseases. 

Margaret has broad functional experience spanning strategic planning, business development, deal negotiation, marketing, sales and program management. Her MBA program had a focus on entrepreneurship and venture capital management.